Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about CLUSTERIN: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
CLUSTERIN is a protein involved in neurodegeneration research. Key relationships include: associated with, regulates, activates. Associated with ALS, Aging, Als. Connected to 115 entities in the SciDEX knowledge graph.
| Gene Symbol | CLU |
| Full Name | Clusterin |
| Aliases | Page for CLU Gene |
| Chromosome | 8p21.1 |
| Protein Family | Apolipoprotein / extracellular chaperone |
| Function | It binds to non-native, misfolded, or aggregation-prone proteins and maintains them in a soluble state suitable for subsequent processing (Wyatt et al., 2009) |
| Primary Expression | Secreted (sCLU), cytoplasmic/nuclear (nCLU/iCLU) |
| Molecular Weight | ~75-80 kDa (heterodimer) |
| Amino Acids | 522 aa |
| Exons | 9 |
| Pathways | Apoptosis, Complement, Immune Response, Mitophagy |
| UniProt ID | P10909 |
| NCBI Gene ID | 1115 |
| Ensembl ID | ENSG00000120885 |
| OMIM | 185551 |
| GeneCards | CLU |
| Human Protein Atlas | CLU |
| Associated Diseases | ALS, Aging, Alzheimer, Alzheimer Disease, Alzheimer'S Disease |
| Interactions | LC3, C1Q, BACE1, PI3K, AKT, BAX |
| KG Connections | 292 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
CLUSTERIN["<b>CLUSTERIN</b>"]
Cancer{"Cancer"}
CLUSTERIN -->|"regulates"| Cancer
Neurodegeneration{"Neurodegeneration"}
CLUSTERIN -->|"associated with"| Neurodegeneration
Alzheimer{"Alzheimer"}
CLUSTERIN -->|"associated with"| Alzheimer
CLUSTERIN -->|"activates"| Alzheimer
Als{"Als"}
CLUSTERIN -->|"activates"| Als
CLUSTERIN -->|"activates"| Cancer
CLUSTERIN -->|"expressed in"| Alzheimer
Tumor{"Tumor"}
CLUSTERIN -->|"expressed in"| Tumor
Senescence{"Senescence"}
CLUSTERIN -->|"expressed in"| Senescence
ALS{"ALS"}
CLUSTERIN -->|"causes"| ALS
Parkinson{"Parkinson"}
CLUSTERIN -->|"causes"| Parkinson
LC3["LC3"]
CLUSTERIN -->|"activates"| LC3
CLU["CLU"]
CLU -->|"regulates"| CLUSTERIN
PPARGC1A["PPARGC1A"]
PPARGC1A -->|"regulates"| CLUSTERIN
BAX["BAX"]
BAX -->|"activates"| CLUSTERIN
C1S["C1S"]
C1S -->|"regulates"| CLUSTERIN
PPARG["PPARG"]
PPARG -->|"regulates"| CLUSTERIN
CLU -->|"activates"| CLUSTERIN
CLU -->|"therapeutic target"| CLUSTERIN
BAX -->|"regulates"| CLUSTERIN
C1Q["C1Q"]
C1Q -->|"activates"| CLUSTERIN
RS6656401["RS6656401"]
RS6656401 -->|"associated with"| CLUSTERIN
RS3919533["RS3919533"]
RS3919533 -->|"associated with"| CLUSTERIN
BIN1["BIN1"]
BIN1 -->|"activates"| CLUSTERIN
style CLUSTERIN fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer's disease pathology | involved_in | mechanism | 0.85 |
| Plasma complement protein levels | biomarker_for | biomarker | 0.80 |
| Immune dysregulation | involved_in | process | 0.80 |
| Alzheimer | associated_with | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Apoptosis | activates | pathway | 0.70 |
| Parkinson's Disease | biomarker_for | disease | 0.70 |
| ALZHEIMER | associated_with | gene | 0.70 |
| Cancer | regulates | disease | 0.65 |
| Neurodegeneration | associated_with | disease | 0.65 |
| Alzheimer | activates | disease | 0.65 |
| Cancer | activates | disease | 0.65 |
| Alzheimer | expressed_in | disease | 0.65 |
| Tumor | expressed_in | disease | 0.65 |
| Senescence | expressed_in | disease | 0.65 |
| ALS | causes | disease | 0.65 |
| Parkinson | causes | disease | 0.65 |
| Dementia | associated_with | disease | 0.65 |
| Aging | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Parkinson | activates | disease | 0.65 |
| Als | regulates | disease | 0.65 |
| Dementia | regulates | disease | 0.65 |
| Multiple Sclerosis | activates | disease | 0.65 |
| Ms | therapeutic_target | disease | 0.65 |
| Als | therapeutic_target | disease | 0.65 |
| Parkinson | therapeutic_target | disease | 0.65 |
| Parkinson's Disease | associated_with | disease | 0.65 |
| Alzheimer | contributes_to | disease | 0.65 |
| Als | expressed_in | disease | 0.65 |
| Aging | contributes_to | disease | 0.65 |
| ALS | expressed_in | disease | 0.65 |
| Inflammation | contributes_to | disease | 0.65 |
| Inflammation | regulates | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| ALS | interacts_with | disease | 0.65 |
| Alzheimer | interacts_with | disease | 0.65 |
| LC3 | activates | gene | 0.60 |
| PPARG | regulates | gene | 0.60 |
| C1Q | activates | gene | 0.60 |
| CR1 | regulates | gene | 0.60 |
| CFH | associated_with | gene | 0.60 |
| BACE1 | activates | gene | 0.60 |
| LC3 | regulates | gene | 0.60 |
| PPARGC1A | regulates | gene | 0.60 |
| C1S | regulates | gene | 0.60 |
| CLU | regulates | gene | 0.60 |
| PICALM | associated_with | gene | 0.60 |
| TNF | associated_with | gene | 0.60 |
| APOE | associated_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| BACE1 | regulates_expression | gene | 0.90 |
| CLU | regulates | gene | 0.70 |
| APOPTOSIS | activates | gene | 0.70 |
| PPARGC1A | regulates | gene | 0.60 |
| BAX | activates | gene | 0.60 |
| C1S | regulates | gene | 0.60 |
| PPARG | regulates | gene | 0.60 |
| CLU | activates | gene | 0.60 |
| CLU | therapeutic_target | gene | 0.60 |
| BAX | regulates | gene | 0.60 |
| C1Q | activates | gene | 0.60 |
| BIN1 | activates | gene | 0.60 |
| CDKN2A | expressed_in | gene | 0.60 |
| PRKCB | expressed_in | gene | 0.60 |
| BECN1 | expressed_in | gene | 0.60 |
| LC3 | activates | gene | 0.60 |
| TREM2 | associated_with | gene | 0.60 |
| CLU | associated_with | gene | 0.60 |
| SORL1 | associated_with | gene | 0.60 |
| BDNF | associated_with | gene | 0.60 |
| APP | associated_with | gene | 0.60 |
| CR1 | associated_with | gene | 0.60 |
| CLU | expressed_in | gene | 0.60 |
| CFH | implicated_in | gene | 0.60 |
| CR1 | regulates | gene | 0.60 |
| APOE | activates | gene | 0.60 |
| TAU | activates | gene | 0.60 |
| CX3CR1 | expressed_in | gene | 0.60 |
| SORL1 | activates | gene | 0.60 |
| IL6 | expressed_in | gene | 0.60 |
| TGM2 | expressed_in | gene | 0.60 |
| BACE1 | activates | gene | 0.60 |
| AKT | activates | gene | 0.60 |
| PI3K | activates | gene | 0.60 |
| APP | interacts_with | gene | 0.60 |
| REELIN | interacts_with | gene | 0.60 |
| RS6656401 | associated_with | gene | 0.60 |
| RS3919533 | associated_with | gene | 0.60 |
| NEURODEGENERATIVE DISEASES | expressed_in | gene | 0.60 |
| ALZHEIMER'S DISEASE | expressed_in | gene | 0.60 |
| AUTOPHAGY | expressed_in | gene | 0.60 |
| OXIDATIVE STRESS | expressed_in | gene | 0.60 |
| ROS | activates | gene | 0.60 |
| MITOPHAGY | regulates | gene | 0.60 |
| MITOCHONDRIA | regulates | gene | 0.60 |
| CANCER | regulates | gene | 0.60 |
| PARKINSON'S DISEASE | causes | gene | 0.60 |
| GENES | causes | gene | 0.60 |
| PARKINSON | causes | gene | 0.60 |
| ALZHEIMER'S DISEASE | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Magnetosonic-Triggered Transferrin Receptor Clustering | 0.470 | neurodegeneration | Blood-brain barrier transport mechanisms |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.548
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Bispecific brain-penetrant antibodies for treatment of Alzheimer's disease. [PMID:40425446] | Sehlin D, Hultqvist G, Michno W, Aguilar | J Prev Alzheimers Dis | 2025 | 1 |
| Effect of ferroptosis on chronic cerebral hypoperfusion in vascular dementia. [PMID:37709116] | Fu P, Chen Y, Wu M, Bao B, Yin X, Chen Z | Exp Neurol | 2023 | 1 |
| On Iron Metabolism and Its Regulation. [PMID:33925597] | Vogt AS, Arsiwala T, Mohsen M, Vogel M, | Int J Mol Sci | 2021 | 1 |
| Transferrin Receptor Is a Specific Ferroptosis Marker. [PMID:32160546] | Feng H, Schorpp K, Jin J, Yozwiak CE, Ho | Cell Rep | 2020 | 1 |
| Transferrin and transferrin receptors update. [PMID:29969719] | Kawabata H | Free Radic Biol Med | 2019 | 1 |
| A proimmunotoxin nanodrug targeting AIDS-associated non-Hodgkin lymphoma. [PMID:41592623] | Chen S, Qi T, Peng H, Kimura E, Zhang X | J Control Release | 2026 | 0 |
| Time- and dose-dependent effects of bacterial infection on iron metabolism, infl [PMID:41619877] | Lu Y, Zhang Y, Niu C | Comp Biochem Physiol A Mol Int | 2026 | 0 |
| Ayanin combats against barium sulphate nanoparticles induced hepatotoxicity via [PMID:41666660] | Zhu D, Lu Y, Jamil S, Ashfaq H, Al-Emam | J Trace Elem Med Biol | 2026 | 0 |
| Role of iron and TfR1 in the application of high‑dose ascorbate against pancreat [PMID:41789665] | Piotrowsky A, Leischner C, Schmieder H, | Oncol Rep | 2026 | 0 |
| Brain and Liver Dual-Targeting Oridonin Nanoparticles to Enhance Aβ Clearance fo [PMID:41944296] | Gong W, Hui W, Qiao S, Ji Q, Liu M et al | Adv Sci (Weinh) | 2026 | 0 |
| Cerebrospinal Fluid from Restless Legs Syndrome Patients Reduces Iron Uptake in [PMID:41947413] | Palsa K, Sahu AP, Rye DB, Trotti LM, Elc | Ann Neurol | 2026 | 0 |
| Pulmonary neuroendocrine cell-derived exosomes regulate iron homeostasis and oxi [PMID:41950316] | Thakur A, Zhang K, Chen J, Mei S, Chen J | Sci Adv | 2026 | 0 |
| O-GlcNAc Modification Orchestrates HUWE1-Mediated Ubiquitination of TfR1 to Regu [PMID:41962599] | Zhang H, Li M, Zhang J, Sun Q, Jin X et | Free Radic Biol Med | 2026 | 0 |
| Protective Role of Polydatin Against Vancomycin-Induced Lung Toxicity via Oxidat [PMID:41963266] | Aygörmez S, Küçükler S, Çomaklı S, Şimşe | J Appl Toxicol | 2026 | 0 |
| Yangxin granules exert cardioprotective effects against acute myocardial infarct [PMID:41868900] | Huo G, Zhou Y, Wu Z, Sun S, Zhu G, Cheng | American journal of translatio | 2026 | 0 |
| Conformational dynamics study of TfR1 upon transferrin binding via NMA and MD si [PMID:41921418] | Zemmouche M, Falque G, Cadet F, Gardebie | Journal of molecular graphics | 2026 | 0 |
| [Effects of acupuncture on ferroptosis and ferritinophagy in cerebral ischemia-r [PMID:41839581] | Wang YF, Dong YS | Zhen ci yan jiu = Acupuncture | 2026 | 0 |
| The therapeutic potential of Piezo1 channel-mediated ferroptosis and its inhibit [PMID:41854751] | Nan K, Zhang L, Zhao Y, Yin S, Peng Y, H | Apoptosis : an international j | 2026 | 0 |
| The Role of Artemisinin and its Derivatives in Cancer Therapy via Ferroptosis: A [PMID:41833023] | Osmanlioglu Dag SR, Tatli Cankaya II, Oz | Anti-cancer agents in medicina | 2026 | 0 |
| Raccoon eyes. [PMID:35789012] | Ning J | Journal of paediatrics and chi | 2023 | 0 |